Discontinued — last reported Q2 '24

Business Segments · Business acquisitions

SaaS — Business acquisitions

Over 3 years (FY 2021 to FY 2024), SaaS — Business acquisitions shows a downward trend with a -100.0% CAGR.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ3 2018
Last reportedQ2 2024

How to read this metric

Higher spending indicates an aggressive inorganic growth strategy, while lower spending suggests a focus on organic growth or integration of existing assets.

Detailed definition

This metric tracks the total cash outflow or consideration paid for the acquisition of businesses or assets specifically...

Peer comparison

Similar to M&A spend metrics in technology-focused segments of healthcare companies, often benchmarked against segment revenue growth rates.

Metric ID: rmd_segment_saas_business_acquisitions

Historical Data

13 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24
Value$4.71M$0.00$0.00$0.00$0.00$0.00$780.72M$3.35M$0.00$0.00$0.00$0.00$0.00
QoQ Change-100.0%-99.6%-100.0%
YoY Change-100.0%-100.0%-100.0%
Range$0.00$780.72M
CAGR-100.0%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is ResMed's saas — business acquisitions?
ResMed (RMD) reported saas — business acquisitions of $0.00 in Q2 2024.
What is the long-term trend for ResMed's saas — business acquisitions?
Over 3 years (2021 to 2024), ResMed's saas — business acquisitions has grown at a -100.0% compound annual growth rate (CAGR), from $18.84M to $0.00.
What does saas — business acquisitions mean?
The total capital spent to acquire other companies or business units to expand the SaaS segment.